Pulmonary arterial hypertension (PAH) is a rare, chronic disease of the pulmonary vasculature that is associated with poor outcomes. Its pathogenesis is multifactorial and includes micro-RNA (miRNA) deregulation. The understanding of the role of miRNAs in PAH is expanding quickly, and it is increasingly difficult to identify which miRNAs have the highest translational potential. This review summarizes the current knowledge of miRNA expression in PAH, discusses the challenges in miRNA analysis and interpretation, and highlights 4 promising miRNAs in this field (miR-29, miR-124, miR-140, and miR-204).
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691282 | PMC |
| http://dx.doi.org/10.1016/j.jacbts.2020.07.008 | DOI Listing |
Publication Analysis
Top Keywords
pulmonary arterial
8
arterial hypertension
8
current knowledge
8
micro-rna analysis
4
analysis pulmonary
4
hypertension current
4
knowledge challenges
4
challenges pulmonary
4
hypertension pah
4
pah rare
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!